BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9062847)

  • 1. Species differences in the renal toxicity of the antiarthritic drug, gold sodium thiomalate.
    Cheriathundam E; Alvares AP
    J Biochem Toxicol; 1996; 11(4):175-81. PubMed ID: 9062847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of repeated administration of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.
    Takahashi Y; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):253-6. PubMed ID: 1604050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of heme metabolism and monooxygeneses in liver and kidney: influence of therapeutically used gold compounds.
    Gondal JA; Eiseman JL; Alvares AP
    J Pharmacol Exp Ther; 1987 May; 241(2):540-6. PubMed ID: 3106619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute nephropathy induced by gold sodium thiomalate: alterations in renal heme metabolism and morphology.
    Eiseman JL; Ribas JL; Knight E; Alvares AP
    Toxicol Appl Pharmacol; 1987 Nov; 91(2):193-203. PubMed ID: 3118510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.
    Takahashi Y; Funakoshi T; Shimada H; Kojima S
    Toxicology; 1994 May; 90(1-2):39-51. PubMed ID: 8023341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of hepatic and renal cytochromes P-450-dependent monooxygenases from fuzzy and Sprague-Dawley rats.
    Cheriathundam E; Almirez R; Alvares AP
    Drug Metab Dispos; 1992; 20(1):19-22. PubMed ID: 1346991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of chelating agents as antidotes for nephrotoxicity of gold sodium thiomalate in adjuvant-arthritic rats.
    Takahashi Y; Funakoshi T; Shimada H; Kojima S
    Toxicology; 1995 Mar; 97(1-3):151-7. PubMed ID: 7716781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antirheumatic gold compounds on the conversion of xanthine dehydrogenase to oxidase in rabbit liver cytosol in vitro.
    Sakuma S; Gotoh K; Sadatoku N; Fujita T; Fujimoto Y
    Life Sci; 2004 Jul; 75(10):1211-8. PubMed ID: 15219809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
    Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
    Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of chelating agents against renal toxicity of gold sodium thiomalate in rats.
    Kojima S; Takahashi Y; Kiyozumi M; Tagawa Y
    Arch Toxicol; 1991; 65(7):532-6. PubMed ID: 1664200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress protein synthesis induced in rat liver by cadmium precedes hepatotoxicity.
    Goering PL; Fisher BR; Kish CL
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):139-48. PubMed ID: 8378928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cd-metallothionein nephrotoxicity in inbred strains of mice.
    Sendelbach LE; Kershaw WC; Cuppage F; Klaassen CD
    J Toxicol Environ Health; 1992 Feb; 35(2):115-26. PubMed ID: 1542133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the chrysotherapeutic agents auranofin and gold sodium thiomalate on hepatic and renal drug metabolism and heme metabolism.
    Leonard TB; Graichen ME; Dahm LJ; Dent JG
    Biochem Pharmacol; 1986 Sep; 35(18):3057-63. PubMed ID: 3092830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity studies of benzophenone (CAS No. 119-61-9). Administered in feed to F344/N rats and B6C3F mice.
    Chhabra RS
    Toxic Rep Ser; 2000 Apr; (61):1-53, A1-13. PubMed ID: 11803700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-(1,2,2-trichlorovinyl)-L-cysteine sulfoxide, a reactive metabolite of S-(1,2,2-Trichlorovinyl)-L-cysteine formed in rat liver and kidney microsomes, is a potent nephrotoxicant.
    Elfarra AA; Krause RJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1095-101. PubMed ID: 17347324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of HF on the hepatic metabolism of dimethylnitrosamine in the rat].
    Bompart G; Dophuoc H; Bourbon P
    Toxicol Eur Res; 1983 Nov; 5(6):273-6. PubMed ID: 6675213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of one-year cadmium exposure on livers and kidneys and their relation to glutathione levels.
    Kamiyama T; Miyakawa H; Li JP; Akiba T; Liu JH; Liu J; Marumo F; Sato C
    Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):177-86. PubMed ID: 7670849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and renal metallothionein induction in the rat and mouse after treatment with furosemide.
    Wormser U; BenZakine S; Nyska A
    Biochem Int; 1991 Jan; 23(2):419-28. PubMed ID: 1859441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.